These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 7740487)

  • 21. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.
    Casini A; Neerman-Arbez M; Ariëns RA; de Moerloose P
    J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for pregnancy associated venous thromboembolism.
    McColl MD; Ramsay JE; Tait RC; Walker ID; McCall F; Conkie JA; Carty MJ; Greer IA
    Thromb Haemost; 1997 Oct; 78(4):1183-8. PubMed ID: 9364982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Myocardial infarction and thromboembolism during pregnancy].
    Härtel D; Sorges E; Carlsson J; Römer V; Tebbe U
    Herz; 2003 May; 28(3):175-84. PubMed ID: 12756475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
    Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE
    Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA.
    Engesser L; Koopman J; de Munk G; Haverkate F; Nováková I; Verheijen JH; Briët E; Brommer EJ
    Thromb Haemost; 1988 Aug; 60(1):113-20. PubMed ID: 3142089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders?
    Bevan DH
    Thromb Res; 2009 Dec; 124 Suppl 2():S12-6. PubMed ID: 20109651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism--results of the Spanish Multicentric Study on Thrombophilia (EMET-Study).
    Mateo J; Oliver A; Borrell M; Sala N; Fontcuberta J
    Thromb Haemost; 1997 Mar; 77(3):444-51. PubMed ID: 9065991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.
    Gschwandtner ME; Eichinger S; Hütter D; Korninger L; Lechner K; Panzer S; Pabinger I
    Blood Coagul Fibrinolysis; 1996 Apr; 7(3):325-30. PubMed ID: 8735139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
    Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
    Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activated protein C resistance as a cause of thrombophilia].
    Ruiz-Argüelles GJ
    Rev Invest Clin; 1996; 48(3):223-9. PubMed ID: 8966383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
    James AH; Brancazio LR; Ortel TL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Obstetrical management of dysfibrinogenemia with increased thrombophilia].
    Klein M; Rosen A; Kyrle P; Beck A
    Geburtshilfe Frauenheilkd; 1992 Jul; 52(7):442-4. PubMed ID: 1499957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis of thrombophilia based on coagulation and genetic studies].
    Bałszan-Kowalska I
    Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and treatment of congenital fibrinogen deficiency.
    Peyvandi F
    Thromb Res; 2012 Dec; 130 Suppl 2():S7-11. PubMed ID: 23439004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular basis of inherited thrombophilia.
    Manucci PM
    Vox Sang; 2000; 78 Suppl 2():39-45. PubMed ID: 10938925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S.
    De Stefano V; Leone G; Mastrangelo S; Tripodi A; Rodeghiero F; Castaman G; Barbui T; Finazzi G; Bizzi B; Mannucci PM
    Thromb Haemost; 1994 Sep; 72(3):352-8. PubMed ID: 7855783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombophilia in patients with venous thromboembolism].
    Rodríguez Pinto MC; Fernández Urgellés M; Soto Ortega I; García Gala JM; Rosón Porto C; Corte Buelga JR
    Sangre (Barc); 1996 Feb; 41(1):37-42. PubMed ID: 8779033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.